Key Insights

Highlights

Treatment Research

2 treatments under study, led by Intravitreal Triamcinolone Injection

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
NCT00300014Not ApplicableUnknownPrimary

Efficacy and Safety of Intravitreal Triamcinolone Acetonide in Eyes With Post Vitrectomy Diabetic Vitreous Hemorrhage

Showing all 1 trials

Research Network

Common Treatments

  • Intravitreal Triamcinolone Injection1
  • Airfluid Exchange1

Active Sponsors

  • Asan Medical Center1

Top Investigators

Related Conditions

  • Recurrent Diabetic Vitreous Hemorrhage1

Activity Timeline